C. Greg Guyer, Ph.D.

C. Greg Guyer, Ph.D.

Executive Vice President, Chief Technical OfficeratBiomarin Pharmaceutical· In proxies 2021–2025

Pay in FY2025+13% from the year before · Biomarin Pharmaceutical stock -9.6% the same year

C. Greg Guyer, Ph.D. was paid $5.7M in FY2025 (Dec), up 13%. Biomarin Pharmaceutical stock fell 9.6% that year.

Pay$100 in the stock at the end of FY20 → $68
Pay is from the Summary Compensation Table of each Biomarin Pharmaceutical proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Biomarin PharmaceuticalPublic company · 5 yr
    • Executive Vice President, Chief Technical Officer2021 – Present · 5 yrStock in role -37%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?